
Myopia, commonly called nearsightedness, is a refractive condition in which distant objects appear blurry while close objects remain clear. It occurs when the eye grows too long (axial elongation) or when the cornea has too much curvature, causing light to focus in front of the retina instead of directly on it. This refractive mismatch leads to blurred distance vision, eyestrain, headaches, and often a need for stronger eyeglasses or contact lens prescriptions over time.
Myopia is one of the most prevalent vision conditions worldwide, particularly among children and young adults. Conventional explanations have focused primarily on genetic factors, prolonged near work, and reduced outdoor time as key contributors.
However, cutting-edge research now suggests that inflammatory processes within the eye play a crucial role in the underlying disease mechanism, particularly in progressive myopia.
Emerging scientific evidence shows that myopia is not merely a mechanical refractive error but involves complex biological processes including ocular inflammation and immune signaling:
This emerging view reframes myopia as a dynamic interplay between environmental triggers, visual stressors, and immunological responses, rather than a purely structural refractive condition.



Signs of myopia often develop gradually and may include:
Unchecked myopia progression — especially in children and teenagers — increases the likelihood of high myopia and associated complications such as retinal detachment, glaucoma, and myopic maculopathy. Understanding and addressing underlying factors like inflammation and tissue remodeling early can slow progression and support healthier visual outcomes.

At Netra Eye Institute, we integrate advanced holistic modalities to address not just the symptoms but the root contributors to myopia progression.
Netra Restoration Therapy (NRT) is an innovative, multi-modal vision therapy rooted in holistic integrative ophthalmic care. Designed to support natural visual function, NRT targets:
By addressing inflammation and supporting tissue healing, NRT aims to stabilize or improve visual clarity, assist in reducing the rate of prescription changes, and enhance overall ocular health — without reliance solely on corrective lenses or conventional pharmaceutical intervention.
While glasses correct the blur, Netra Restoration Therapy (NRT) focuses on the underlying condition associated with cause of myopia and its progression
Many patients experience changes in visual comfort and performance within the first few weeks of therapy, with ongoing benefits as part of a customized plan.
Can myopia be reversed?
While traditional eyeglasses and contact lenses correct refractive error, they do not address underlying biological contributors. NRT focuses on the root mechanisms that support healthier visual function, potentially slowing progression and improving quality of vision.
Is NRT suitable for children?
Yes. Early intervention during childhood or adolescent development — a period of ocular plasticity — can be particularly impactful when paired with guidance on visual habits and environmental factors.
How soon will I see results?
Many patients report subjective improvements within a few weeks of beginning NRT, though treatment duration varies by individual needs and severity of condition.
Myopia doesn’t have to be a life sentence of steadily worsening prescriptions. Through a deeper understanding of the role inflammation plays in myopia, and with personalized care through Netra Restoration Therapy, we offer a comprehensive strategy for healthier vision now — and into the future.
Our signature Netra Restoration Therapy is a unique treatment method available exclusively at Netra Eye Institute, which has shown to halt AMD progression, improve visual acuity, reduce foggy/hazy vision, improve contrast sensitivity and reduce glare.
The Mechanism of Action (MOA) of Netra Restoration Therapy works by enhancing ocular blood flow through the regulation of vascular function, reducing oxidative stress and ocular inflammation, increasing neurotrophin levels and neuroprotection, and reducing ferroptosis.
The potential for visual improvement depends on the severity of retinal damage present at the time of treatment for Wet AMD. Taking these factors into account, our therapeutic approach has been shown to result in:

Stops vision loss progression by reducing the ocular inflammation, regulating ocular blood flow and nourshing the retinal cells.

Improvement in visual field by restoring
dormant and unhealthy retinal cells.

An improvement of at least one line on the distance and near vision eye chart.

Improved contrast vision, making it easier to distinguish shapes, edges, and details.

Improvement in color, brightness perception and clarity making it easier to see in low-light or nighttime conditions, thereby supporting safer mobility and daily activities.

Reduced glare, less light sensitivity, and improved comfort in bright environments, such as sunlight, headlights, or digital screens.

Patients experience considerable reduction
in eye pain and eye strains.

Patients often report feeling “healthier overall,” not just in their eyes.
Netra Restoration Therapy is grounded in contemporary biomedical research demonstrating that many eye diseases are driven by reduced ocular blood flow, ongoing neurodegeneration, and cellular stress. Scientific studies show that improving vascular regulation enhances oxygen and nutrient delivery to the retina and optic nerve, while supporting neurotrophin activity and neuroprotection helps preserve vulnerable nerve cells. At the same time, controlling oxidative stress, ferroptosis, and chronic inflammation is critical to slowing tissue damage and disease progression. Netra Restoration integrates these evidence-based principles into a comprehensive approach designed to support long-term eye health and visual function.